Skip to main content
Top
Published in: Rheumatology International 12/2012

01-12-2012 | Original Article

Low plasma vitamin D levels in patients with familial Mediterranean fever

Authors: Şükran Erten, Alpaslan Altunoğlu, Gülay Güleç Ceylan, Yüksel Maraş, Cemile Koca, Aydan Yüksel

Published in: Rheumatology International | Issue 12/2012

Login to get access

Abstract

Familial Mediterranean fever (FMF) is an autosomal recessive, inherited autoinflammatory disease characterized by recurrent, self-limited attacks of fever and inflammation of serosal surfaces. There is an explosion of the data regarding inflammatory markers in FMF and clinical effects of chronic inflammation on the disease presentation. Vitamin D (vit D) is the common denomination of a group of sterols with a crucial role in phospho-calcium metabolism. There are some data about the importance of vit D in the initiation and propogation of a range of autoimmune diseases. The aim of the present study was to determine whether vit D deficiency is present in patients with FMF compared with healthy individuals. The study group included 99 patients with diagnosis of FMF attended to our outpatient Rheumatology and Nephrology Clinics of Atatürk Education and Research Hospital. The control group comprised 51 age- and sex-matched healthy people selected from hospital staff. Serum baseline 25-hydroxy vit D levels were measured by HPLC method using an Agilent 1100 Liquid Chromatograph. We found significantly lower serum 25-hydroxy vit D levels among FMF patients compared with matched controls and a high prevalence of vit D deficiency. This study demonstrated that vit D deficiency is frequent in patients with FMF than the healthy controls. It is convenient to look for vit D deficiency and to correct vit D nutritional status in FMF patients.
Literature
1.
go back to reference Ben-Zvi I, Livneh A (2010) Chronic inflammation in FMF: markers, risk factors, outcomes and therapy. Nat Rev Rheumatol [Epub ahead of print] Ben-Zvi I, Livneh A (2010) Chronic inflammation in FMF: markers, risk factors, outcomes and therapy. Nat Rev Rheumatol [Epub ahead of print]
2.
go back to reference Jarjour RA, Dodaki R (2011) Arthritis patterns in familial Mediterranean fever patients and association with M694V mutation. Mol Biol Rep 38(3):2033–2036PubMedCrossRef Jarjour RA, Dodaki R (2011) Arthritis patterns in familial Mediterranean fever patients and association with M694V mutation. Mol Biol Rep 38(3):2033–2036PubMedCrossRef
3.
go back to reference Ozen S (2009) Mutations/polymorphisms in a monogenetic autoinflammatory disease may be susceptibility markers for certain rheumatic diseases: lessons from the bedside for the benchside. Clin Exp Rheumatol 27(2 Suppl 53):S29–S31PubMed Ozen S (2009) Mutations/polymorphisms in a monogenetic autoinflammatory disease may be susceptibility markers for certain rheumatic diseases: lessons from the bedside for the benchside. Clin Exp Rheumatol 27(2 Suppl 53):S29–S31PubMed
4.
go back to reference Ruiz-Irastorza G, Egurbide MV, Olivares N, Martinez-Berriotxoa A, Aguirre C (2008) Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences. Rheumatology (Oxford) 47(6):920–923CrossRef Ruiz-Irastorza G, Egurbide MV, Olivares N, Martinez-Berriotxoa A, Aguirre C (2008) Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences. Rheumatology (Oxford) 47(6):920–923CrossRef
5.
go back to reference Livneh A, Langevitz P, Zemer D et al (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40(10):1879–1885PubMedCrossRef Livneh A, Langevitz P, Zemer D et al (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40(10):1879–1885PubMedCrossRef
6.
go back to reference Leventis P, Patel S (2008) Clinical aspects of vitamin D in the management of rheumatoid arthritis. Rheumatology (Oxford) 47(11):1617–1621CrossRef Leventis P, Patel S (2008) Clinical aspects of vitamin D in the management of rheumatoid arthritis. Rheumatology (Oxford) 47(11):1617–1621CrossRef
8.
go back to reference Cutolo M (2008) Vitamin D or hormone D deficiency in autoimmune rheumatic diseases, including undifferentiated connective tissue disease. Arthritis Res Ther 10(6):123PubMedCrossRef Cutolo M (2008) Vitamin D or hormone D deficiency in autoimmune rheumatic diseases, including undifferentiated connective tissue disease. Arthritis Res Ther 10(6):123PubMedCrossRef
9.
go back to reference Yuksel S, Samli H, Colbay M et al (2009) Increased serum osteoprotegerin levels associated with decreased bone mineral density in familial Mediterranean fever. Tohoku J Exp Med 217(4):321–327PubMedCrossRef Yuksel S, Samli H, Colbay M et al (2009) Increased serum osteoprotegerin levels associated with decreased bone mineral density in familial Mediterranean fever. Tohoku J Exp Med 217(4):321–327PubMedCrossRef
10.
go back to reference Suyani E, Ozturk MA, Deger SM, Demirag MD, Goker B, Haznedaroglu S (2008) Decreased bone mineral density in adult familial Mediterranean fever patients: a pilot study. Clin Rheumatol 27(9):1171–1175PubMedCrossRef Suyani E, Ozturk MA, Deger SM, Demirag MD, Goker B, Haznedaroglu S (2008) Decreased bone mineral density in adult familial Mediterranean fever patients: a pilot study. Clin Rheumatol 27(9):1171–1175PubMedCrossRef
11.
go back to reference Yıldırım K, Karatay S, Cetinkaya R et al (2010) Bone mineral density in patients with familial Mediterranean fever. Rheumatol Int 30(3):305–308PubMedCrossRef Yıldırım K, Karatay S, Cetinkaya R et al (2010) Bone mineral density in patients with familial Mediterranean fever. Rheumatol Int 30(3):305–308PubMedCrossRef
12.
go back to reference Lange U, Teichmann J, Strunk J, Müller-Ladner U, Schmidt KI (2005) Association of 1.25 vitamin D3 deficiency, disease activity and low bone mass in ankylosing spondylitis. Osteoporos Int 16(12):1999–2004PubMedCrossRef Lange U, Teichmann J, Strunk J, Müller-Ladner U, Schmidt KI (2005) Association of 1.25 vitamin D3 deficiency, disease activity and low bone mass in ankylosing spondylitis. Osteoporos Int 16(12):1999–2004PubMedCrossRef
13.
go back to reference Warner AE, Arnspiger SA (2008) Diffuse musculoskeletal pain is not associated with low vitamin D levels or improved by treatment with vitamin D. J Clin Rheumatol 14(1):12–16PubMedCrossRef Warner AE, Arnspiger SA (2008) Diffuse musculoskeletal pain is not associated with low vitamin D levels or improved by treatment with vitamin D. J Clin Rheumatol 14(1):12–16PubMedCrossRef
14.
go back to reference Kamen D, Aranow C (2008) Vitamin D in systemic lupus erythematosus. Curr Opin Rheumatol 20(5):532–537PubMedCrossRef Kamen D, Aranow C (2008) Vitamin D in systemic lupus erythematosus. Curr Opin Rheumatol 20(5):532–537PubMedCrossRef
Metadata
Title
Low plasma vitamin D levels in patients with familial Mediterranean fever
Authors
Şükran Erten
Alpaslan Altunoğlu
Gülay Güleç Ceylan
Yüksel Maraş
Cemile Koca
Aydan Yüksel
Publication date
01-12-2012
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 12/2012
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-2281-4

Other articles of this Issue 12/2012

Rheumatology International 12/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.